These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19209680)

  • 1. The role of PI3K signalling in the B cell response to antigen.
    Hodson DJ; Turner M
    Adv Exp Med Biol; 2009; 633():43-53. PubMed ID: 19209680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3K in lymphocyte development, differentiation and activation.
    Okkenhaug K; Vanhaesebroeck B
    Nat Rev Immunol; 2003 Apr; 3(4):317-30. PubMed ID: 12669022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontline: The p85alpha isoform of phosphoinositide 3-kinase is essential for a subset of B cell receptor-initiated signaling responses.
    Hess KL; Donahue AC; Ng KL; Moore TI; Oak J; Fruman DA
    Eur J Immunol; 2004 Nov; 34(11):2968-76. PubMed ID: 15384044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dynamics of protein kinase B regulation during B cell antigen receptor engagement.
    Astoul E; Watton S; Cantrell D
    J Cell Biol; 1999 Jun; 145(7):1511-20. PubMed ID: 10385529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3K signaling controls cell fate at many points in B lymphocyte development and activation.
    Donahue AC; Fruman DA
    Semin Cell Dev Biol; 2004 Apr; 15(2):183-97. PubMed ID: 15209378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of PI3K in the generation and survival of B cells.
    Werner M; Hobeika E; Jumaa H
    Immunol Rev; 2010 Sep; 237(1):55-71. PubMed ID: 20727029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell receptor signaling: picky about PI3Ks.
    Limon JJ; Fruman DA
    Sci Signal; 2010 Aug; 3(134):pe25. PubMed ID: 20699473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development.
    Ramadani F; Bolland DJ; Garcon F; Emery JL; Vanhaesebroeck B; Corcoran AE; Okkenhaug K
    Sci Signal; 2010 Aug; 3(134):ra60. PubMed ID: 20699475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
    Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
    Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement for phosphoinositide 3-kinase p110delta signaling in B cell antigen receptor-mediated antigen presentation.
    Al-Alwan MM; Okkenhaug K; Vanhaesebroeck B; Hayflick JS; Marshall AJ
    J Immunol; 2007 Feb; 178(4):2328-35. PubMed ID: 17277138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell receptor (BCR) cross-talk: IL-4 creates an alternate pathway for BCR-induced ERK activation that is phosphatidylinositol 3-kinase independent.
    Guo B; Rothstein TL
    J Immunol; 2005 May; 174(9):5375-81. PubMed ID: 15843535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow Cytometry Analysis of mTOR Signaling in Antigen-Specific B Cells.
    Huang Q; Wang H; Xu L; Hu J; Wang P; Li Y; Ye L
    Methods Mol Biol; 2018; 1707():95-109. PubMed ID: 29388102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
    Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
    J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation.
    Baracho GV; Miletic AV; Omori SA; Cato MH; Rickert RC
    Curr Opin Immunol; 2011 Apr; 23(2):178-83. PubMed ID: 21277760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
    Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
    J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation.
    Iwata S; Yamaoka K; Niiro H; Nakano K; Wang SP; Akashi K; Tanaka Y
    J Allergy Clin Immunol; 2012 Jun; 129(6):1594-601.e2. PubMed ID: 22541243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD19 differentially regulates BCR signalling through the recruitment of PI3K.
    Xu Y; Fairfax K; Light A; Huntington ND; Tarlinton DM
    Autoimmunity; 2014 Nov; 47(7):430-7. PubMed ID: 24953501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct roles of phosphoinositide-3 kinase and phospholipase Cgamma2 in B-cell receptor-mediated signal transduction.
    Dai X; Chen Y; Schuman J; Hua Z; Adamson JW; Wen R; Wang D
    Mol Cell Biol; 2006 Jan; 26(1):88-99. PubMed ID: 16354682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p85beta regulatory subunit of phosphoinositide 3-kinase has unique and redundant functions in B cells.
    Oak JS; Chen J; Peralta RQ; Deane JA; Fruman DA
    Autoimmunity; 2009 Aug; 42(5):447-58. PubMed ID: 19811262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXO1 transcription factor: a critical effector of the PI3K-AKT axis in B-cell development.
    Szydłowski M; Jabłońska E; Juszczyński P
    Int Rev Immunol; 2014 Mar; 33(2):146-57. PubMed ID: 24552152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.